A detailed history of Coldstream Capital Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,166 shares of UTHR stock, worth $781,644. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,166
Previous 2,087 3.79%
Holding current value
$781,644
Previous $664,000 16.87%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$311.04 - $363.55 $24,572 - $28,720
79 Added 3.79%
2,166 $776,000
Q2 2024

Aug 07, 2024

BUY
$228.26 - $319.04 $18,489 - $25,842
81 Added 4.04%
2,087 $664,000
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $8,219 - $9,730
-39 Reduced 1.91%
2,006 $460,000
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $17,620 - $21,069
-82 Reduced 3.86%
2,045 $449,000
Q3 2023

Nov 02, 2023

BUY
$211.82 - $248.24 $6,990 - $8,191
33 Added 1.58%
2,127 $480,000
Q2 2023

Aug 03, 2023

BUY
$205.19 - $232.99 $17,646 - $20,037
86 Added 4.28%
2,094 $462,000
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $3,194 - $4,142
-15 Reduced 0.74%
2,008 $449,000
Q4 2022

Jan 10, 2023

BUY
$205.95 - $280.43 $7,002 - $9,534
34 Added 1.71%
2,023 $0
Q2 2022

Aug 08, 2022

BUY
$174.81 - $241.14 $186,347 - $257,055
1,066 Added 115.49%
1,989 $468,000
Q2 2022

Aug 08, 2022

SELL
$174.81 - $241.14 $148,763 - $205,210
-851 Reduced 47.97%
923 $217,000
Q1 2022

May 11, 2022

SELL
$166.16 - $213.96 $8,141 - $10,484
-49 Reduced 2.69%
1,774 $318,000
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $336,015 - $393,913
1,823 New
1,823 $394,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.